← Open Payments lookup

KATHRYN CLABORN: Open Payments

NPI 1295220549 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,018 in 114 payments from 20 companies in 2025. Trend: 2023 $1,576 · 2024 $1,643 · 2025 $2,018

Food & beverage: $2,018
CompanyPaymentsAmount
Novo Nordisk Inc21$369
Dexcom, Inc.13$246
BETA BIONICS, INC.14$240
Bayer Healthcare Pharmaceuticals Inc.13$182
Corcept Therapeutics8$148
Lilly USA, LLC8$128
Insulet Corporation6$117
Abbott Laboratories6$111
Medtronic, Inc.4$83
Esperion Therapeutics, Inc.4$60

Products named: Dexcom G6 Transmitter, iLet Bionic Pancreas, Kerendia, Ozempic, Korlym, Rybelsus, Omnipod, MOUNJARO.

Industry payments across LA — which companies pay providers there.